Effective imaging and treatment of Acute Myeloid Leukemia with radiotheranostics targeting the activated conformation of integrin-ßeta2. Read more about Effective imaging and treatment of Acute Myeloid Leukemia with radiotheranostics targeting the activated conformation of integrin-ßeta2.
Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myeloma. Read more about Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myeloma.
Cul5Wsb2 uses BCL2 proteins as co-receptors to target Bim for degradation. Read more about Cul5Wsb2 uses BCL2 proteins as co-receptors to target Bim for degradation.
Spatiotemporal control of cortical centrin patterning by regionalized Sfi1 family scaffolding proteins in Stentor coeruleus. Read more about Spatiotemporal control of cortical centrin patterning by regionalized Sfi1 family scaffolding proteins in Stentor coeruleus.
Genetic and Epigenetic Reprogramming of Transposable Elements Drives ecDNA-Mediated Metastatic Prostate Cancer. Read more about Genetic and Epigenetic Reprogramming of Transposable Elements Drives ecDNA-Mediated Metastatic Prostate Cancer.
The Hsp40 co-chaperone DNAJC7 modifies polyglutamine but not polyglycine aggregation. Read more about The Hsp40 co-chaperone DNAJC7 modifies polyglutamine but not polyglycine aggregation.
Alanine catabolism as a targetable vulnerability for MYC-driven liver cancer. Read more about Alanine catabolism as a targetable vulnerability for MYC-driven liver cancer.
Defined human tri-lineage brain microtissues. Read more about Defined human tri-lineage brain microtissues.
Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms. Read more about Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms.
Reversible therapeutic resistance in EGFR mutant lung cancer caused by RB1 loss induced lineage plasticity. Read more about Reversible therapeutic resistance in EGFR mutant lung cancer caused by RB1 loss induced lineage plasticity.
